What does SBI Life Insuran do?

SBI Life Insurance Company Ltd, established in 2001 as a joint venture between the State Bank of India and BNP Paribas Cardif S.A., is a leading life insurance provider in India with a market cap of Rs 178,198 Cr and reported net sales of 23,861 Cr and net profit of 814 Cr for March 2025. Key metrics include a P/E ratio of 74.00 and a return on equity of 14.21%.

Overview:<BR>SBI Life Insurance Company Ltd is a leading life insurance provider in India, operating within the large-cap insurance industry.<BR><BR>History:<BR>Established in 2001, SBI Life Insurance is a joint venture between the State Bank of India and BNP Paribas Cardif S.A. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 23,861 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 814 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 178,198 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 74.00<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.15%<BR>- Debt-Equity: -0.11<BR>- Return on Equity: 14.21%<BR>- Price to Book: 10.46<BR><BR>Contact Details:<BR>Address: Natraj M V Road Andheri(East), Western Express Highway Juncti Mumbai Maharashtra : 400069<BR>Tel: 91-22-61910000<BR>Email: investor@sbilife.co.in/aniket.karan<BR>Website: http://www.sbilife.co.in

When is the next results date for SBI Life Insuran?

No Upcoming Board Meetings

Has SBI Life Insuran declared dividend?

Yes, SBI Life Insurance has declared a 27% dividend, amounting to ₹2.7 per share, with an ex-date of March 7, 2025. The company has shown strong total returns across various periods, reflecting its robust financial health.

SBI Life Insurance Company Ltd has declared a 27% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 27%<BR>- Amount per share: 2.7<BR>- Ex-date: 07 Mar 25<BR><BR>Dividend Yield: 0.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 22.37%, the dividend return was 0.18%, leading to a total return of 22.55%.<BR><BR>Over the past year, the price return was 22.87%, the dividend return was 0.19%, resulting in a total return of 23.06%.<BR><BR>In the last 2 years, the price return was 44.93%, the dividend return was 0.42%, culminating in a total return of 45.35%.<BR><BR>For the 3-year period, the price return was 55.37%, the dividend return was 0.74%, which brought the total return to 56.11%.<BR><BR>In the 4-year span, the price return was 79.25%, the dividend return was 0.99%, leading to a total return of 80.24%.<BR><BR>Over the last 5 years, the price return was 122.45%, the dividend return was 1.52%, resulting in a total return of 123.97%.<BR><BR>Overall, SBI Life Insurance has declared a substantial dividend alongside strong total returns across various periods, indicating a positive performance for investors. The consistent growth in both price and dividend returns reflects the company's robust financial health.

Is SBI Life Insuran overvalued or undervalued?

As of April 28, 2025, SBI Life Insurance Co. Ltd. is considered undervalued with a valuation grade shift to very attractive, featuring a PE ratio of 74.03, an EV to EBIT of 131.31, and a year-to-date return of 28.59%, outperforming the Sensex's 5.58%.

As of 28 April 2025, the valuation grade for SBI Life Insurance Co. Ltd. has moved from very expensive to very attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 74.03, an EV to EBIT of 131.31, and a ROE of 14.21%. <BR><BR>In comparison to its peers, SBI Life's valuation metrics align closely with those of similar companies, such as HDFC Life Insurance, which has a PE ratio of approximately 70.00, and ICICI Prudential Life Insurance, with an EV to EBITDA of around 120.00. Notably, SBI Life has outperformed the Sensex with a year-to-date return of 28.59% compared to the Sensex's 5.58%, reinforcing its attractiveness as an investment opportunity.

Who are the peers of the SBI Life Insuran?

SBI Life Insurance's peers include HDFC Life, ICICI Lombard, ICICI Prudential Life, Max Financial, and others. It has an average growth rating and a 1-year return of 12.48%, lower than Max Financial's 50.88% but higher than New India Assurance's -35.73%.

Peers: The peers of SBI Life Insuran are Life Insurance, HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Go Digit General, New India Assura, Star Health Insu, and Niva Bupa Health.<BR><BR>Quality Snapshot: Excellent management risk is observed at ICICI Lombard and Go Digit General, while Average management risk is found at Life Insurance, SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, and Niva Bupa Health, and Below Average management risk is noted at New India Assura. Growth is rated as Excellent for Go Digit General and Niva Bupa Health, Good for HDFC Life Insur., Average for SBI Life Insuran, Life Insurance, General Insuranc, Max Financial, and Star Health Insu, and Below Average for ICICI Pru Life and New India Assura. All peers have an Excellent capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Max Financial at 50.88%, while the peer with the lowest is New India Assura at -35.73%. SBI Life Insuran's 1-year return is 12.48%, which is higher than New India Assura but lower than Max Financial. Additionally, General Insuranc, ICICI Pru Life, New India Assura, and Star Health Insu have negative six-month returns.

Who are in the management team of SBI Life Insuran?

As of March 2023, the management team of SBI Life Insurance includes Chairman Dinesh Kumar Khara, Managing Director & CEO Mahesh Kumar Sharma, and several independent non-executive directors: Deepak Amin, Narayan Seshadri, Shobinder Duggal, T M Bhasin, and Usha Sangwan.

As of March 2023, the management team of SBI Life Insurance includes the following members:<BR><BR>1. Dinesh Kumar Khara - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. Deepak Amin - Independent Non-Executive Director<BR>3. Narayan Seshadri - Independent Non-Executive Director<BR>4. Shobinder Duggal - Independent Non-Executive Director<BR>5. T M Bhasin - Independent Non-Executive Director<BR>6. Usha Sangwan - Independent Non-Executive Director<BR>7. Mahesh Kumar Sharma - Managing Director & CEO<BR><BR>This team comprises a mix of executive and independent directors, with Mahesh Kumar Sharma serving as the CEO.

Who are the top shareholders of the SBI Life Insuran?

The top shareholders of SBI Life Insurance are the State Bank of India with 55.38%, followed by foreign institutional investors at 21.88%, and mutual funds holding 15%. ICICI Prudential Mutual Fund is the largest public shareholder with 4.35%, while individual investors own 2.02%.

The top shareholders of SBI Life Insurance include the State Bank of India, which holds the largest stake at 55.38%. In addition, foreign institutional investors (FIIs) collectively own 21.88% of the shares, while mutual funds have a significant presence with 15.0% held across 42 schemes. The highest public shareholder is ICICI Prudential Mutual Fund, specifically the ICICI Prudential NI, which holds 4.35%. Individual investors account for 2.02% of the holdings.

How big is SBI Life Insuran?

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, with recent Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr. Shareholder's Funds are 14,908.56 Cr and Total Assets are valued at 3,98,298.81 Cr as of March 2024.

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 14,908.56 Cr and Total Assets valued at 3,98,298.81 Cr.

How has been the historical performance of SBI Life Insuran?

SBI Life Insurance has shown consistent growth, with net sales increasing from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, and profit after tax rising from 1,326.80 Cr to 2,413.30 Cr during the same period. Total liabilities and assets both reached 4,57,095.46 Cr in Mar'25, while cash flow from operating activities improved to 25,546.00 Cr.

Answer:<BR>The historical performance of SBI Life Insurance shows a consistent growth trajectory in net sales, with figures rising from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25. Other operating income fluctuated significantly, peaking at 51,400.69 Cr in Mar'24 before dropping to 32,828.59 Cr in Mar'25. Total operating income also saw a peak in Mar'24 at 1,31,987.79 Cr, followed by a decline to 1,16,888.42 Cr in Mar'25. The operating profit (PBDIT) has shown an upward trend, increasing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25. Profit after tax has similarly risen, reaching 2,413.30 Cr in Mar'25, up from 1,326.80 Cr in Mar'19. The earnings per share (EPS) grew from 13.27 in Mar'19 to 24.08 in Mar'25. On the balance sheet, total liabilities increased from 1,65,580.06 Cr in Mar'20 to 4,57,095.46 Cr in Mar'25, while total assets rose from 1,65,580.06 Cr to 4,57,095.46 Cr in the same period. Cash flow from operating activities also improved, reaching 25,546.00 Cr in Mar'25, although cash flow from investing activities remained negative.<BR><BR>Breakdown:<BR>SBI Life Insurance has demonstrated significant growth in net sales, which increased from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, indicating a strong upward trend. Other operating income varied, with a high of 51,400.69 Cr in Mar'24 before decreasing to 32,828.59 Cr in Mar'25. Total operating income peaked at 1,31,987.79 Cr in Mar'24 but fell to 1,16,888.42 Cr in Mar'25. Operating profit (PBDIT) has shown a positive trend, climbing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25, while profit after tax rose from 1,326.80 Cr to 2,413.30 Cr over the same period. The earnings per share (EPS) also increased significantly from 13.27 to 24.08. On the balance sheet, total liabilities and total assets both grew substantially, with total liabilities rising to 4,57,095.46 Cr and total assets matching this figure in Mar'25. Cash flow from operating activities improved to 25,546.00 Cr, despite ongoing negative cash flow from investing activities.

Are SBI Life Insuran latest results good or bad?

SBI Life Insurance's latest results show strong net sales growth of 44.65% quarter-on-quarter, but profitability declined with a 16.77% drop in net profit and a significant contraction in operating profit margins, indicating potential operational challenges. Investors should remain cautious regarding these margin pressures.

SBI Life Insurance's latest results present a mixed picture. On one hand, the company achieved impressive net sales growth of 44.65% quarter-on-quarter, reaching ₹24,848.31 crores, which is also a 22.61% increase year-on-year. This growth was largely driven by strong premium collections during the festive season.<BR><BR>However, the profitability metrics reveal significant concerns. The net profit for the quarter was ₹494.59 crores, which represents a decline of 16.77% compared to the previous quarter, although it shows a modest increase of 6.58% year-on-year. More troubling is the sharp contraction in operating profit margins, which fell to 2.07% from 3.86% in the prior quarter, indicating rising operational challenges, particularly with commission expenses and administrative costs.<BR><BR>Overall, while the top-line growth is commendable, the declining profitability and margin pressures suggest that the results are not entirely positive. Investors should be cautious and monitor whether these margin issues are temporary or indicative of deeper operational challenges.

Should I buy, sell or hold SBI Life Insuran?

Is SBI Life Insuran technically bullish or bearish?

As of 27 October 2025, the trend is bullish with moderate strength, supported by positive daily moving averages and monthly Bollinger Bands, although caution is advised due to mildly bearish weekly indicators; the stock has outperformed the Sensex with a year-to-date return of 36.58%.

As of 27 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include the bullish signals from the daily moving averages and the monthly Bollinger Bands, alongside a bullish monthly MACD. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The stock has shown strong performance relative to the Sensex over various time frames, particularly with a year-to-date return of 36.58% compared to 8.50% for the index.

Which are the latest news on SBI Life Insuran?

Why is SBI Life Insuran falling/rising?

As of 04-Dec, SBI Life Insurance Company's stock price is rising, currently at 1,998.40, with a year-to-date return of 43.43%, significantly outperforming the Sensex. Despite a decline in investor participation, strong fundamentals and positive momentum suggest the stock remains on an upward trajectory.

As of 04-Dec, SBI Life Insurance Company Ltd's stock price is rising, currently at 1,998.40, reflecting an increase of 25.6 (1.3%). This upward movement can be attributed to several factors. Firstly, the stock has shown strong performance over the long term, with a year-to-date return of 43.43%, significantly outperforming the Sensex, which has only increased by 9.12% in the same period. Additionally, the stock has consistently outperformed the broader market over various time frames, including a 37.73% return over the past year and a remarkable 131.69% increase over the last five years.<BR><BR>Moreover, SBI Life is trading above its moving averages, indicating positive momentum. It is also close to its 52-week high, just 4.33% away from Rs 2085, which suggests strong investor interest. The company maintains a low debt-to-equity ratio and has a solid return on equity (ROE) of 13.4, contributing to its attractive valuation. High institutional holdings at 40.54% further support the stock's stability, as these investors typically have better resources to analyze company fundamentals.<BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 41.71% compared to the five-day average. Despite this, the overall market-beating performance and strong fundamentals indicate that the stock is on an upward trajectory.